Purple Biotech
PPBT
14 hedge funds and large institutions have $134K invested in Purple Biotech in 2025 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 0 reducing their positions, and 0 closing their positions.
56% more funds holding
Funds holding: 9 → 14 (+5)
0.44% more ownership
Funds ownership: 0% → 0.44% (+0.44%)
0% less capital invested
Capital invested by funds: $134K → $134K (-$599)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GI
GAMMA Investing
Foster City,
California
|
+$11K |
| 2 |
BNP Paribas Financial Markets
Paris,
France
|
+$2.23K |
| 3 |
Raymond James Financial
St Petersburg,
Florida
|
+$1.38K |
| 4 |
RhumbLine Advisers
Boston,
Massachusetts
|
+$667 |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$272 |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
UBS Group
Zurich,
Switzerland
| $54.3K | +$272 | +11 | +0.5% |
|
|
KWA
2
Kingswood Wealth Advisors
San Diego,
California
| $39.4K | – | – | – |
|
|
3
BNP Paribas Financial Markets
Paris,
France
| $14.7K | +$2.23K | +90 | +17% |
|
4
Morgan Stanley
New York
| $10.7K | +$247 | +10 | +2% |
|
|
GI
5
GAMMA Investing
Foster City,
California
| $10.4K | +$11K | +443 | New |
|
|
6
RhumbLine Advisers
Boston,
Massachusetts
| $2.55K | +$667 | +27 | +33% |
|
|
7
Raymond James Financial
St Petersburg,
Florida
| $1.3K | +$1.38K | +56 | New |
|
8
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
| $199 | – | – | – |
|
|
SS
9
SBI Securities
Tokyo,
Japan
| $47 | – | – | – |
|
|
EWA
10
EverSource Wealth Advisors
Birmingham,
Alabama
| $38 | +$49 | +2 | New |
|
|
GRP
11
Global Retirement Partners
San Rafael,
California
| $38 | +$49 | +2 | New |
|
|
NSIM
12
North Star Investment Management
Chicago,
Illinois
| $35 | – | – | – |
|
13
Simplex Trading
Chicago,
Illinois
| – | +$124 | +5 | New |
|
PPBT Hedge Fund Activity: Q2 2025 in Review
14 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Purple Biotech (PPBT) for Q2 2025, worth a combined $134K — down 0.45% from $134K a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new PPBT positions and 0 closed out — a net gain of 5 holders — while 4 added to existing stakes and 0 trimmed.
The largest buyer was GAMMA Investing, opening a new position worth an estimated $11K.
- 14 institutional investors held Purple Biotech (PPBT) as of Q2 2025, up from 9 in Q1 2025.
- Funds reported $134K of Purple Biotech stock for Q2 2025, down 0.45% quarter-over-quarter.
- 5 funds opened new Purple Biotech positions in Q2 2025 and 0 closed out, a net change of +5 holders.
- The largest Purple Biotech buyer in Q2 2025 was GAMMA Investing, an estimated $11K added.
Based on aggregated 13F filings for Q2 2025.